Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-15

Clinical Trial Update: Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing whether vitamin D treatment reduces mortality in SAR/SARS pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Bioaraba Health Research Institute | Conditions: SAR, SARS Pneumonia | Phase 3 | Status: COMPLETED